The global resistant pseudomonas aeruginosa infections drugs market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Pseudomonas is a type of bacteria. It is found in the environment, such as in soil and water. Pseudomonas aeruginosa infections occur in people with weakened immune systems or in the hospital where there is a high risk of infection and is risky for patients with chronic lung diseases. Moreover, several initiatives such as the progress of new antibiotic formulations and the ant virulence approach are taken into force as a cure against this infection. Hence, due to this, the demand for more advanced antibiotics for the management of hospital-acquired infections which are associated with pseudomonas aeruginosa. These factors are anticipated to drive the growth of the market.
To Request a Sample of our Report on Resistant Pseudomonas Aeruginosa Infections Drugs Market: https://www.omrglobal.com/request-sample/resistant-pseudomonas-aeruginosa-infections-drugs-market
Some major players in the market include Achaogen Inc., Novartis International AG, and Achaogen Inc., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in April 2021, CARB-X announced that it is funding Phico Therapeutics. The funding was aimed to develop a new intravenous engineered bacteriophage drug for the treatment of ventilator-associated pneumonia caused by drug-resistant Pseudomonas aeruginosa.
Market Coverage
- The market number available for – 2020-2027
- Base year- 2020
- Forecast period- 2021-2027
Segment Covered-
- By Type
- By Application
Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape– Achaogen Inc., and Novartis International AG, among others.
(Get 15% Discount on Buying this Report)
A full Report of Resistant Pseudomonas Aeruginosa Infections Drugs Market is Available @ https://www.omrglobal.com/industry-reports/resistant-pseudomonas-aeruginosa-infections-drugs-market
Global Resistant Pseudomonas Aeruginosa Infections Drugs Market Report by Segment
By Type
- Semi-Synthetic Penicillin
- Cephalosporin
- Lactam Drugs
- Others
By Application
- Hospital
- Clinic
- Others
Global Resistant Pseudomonas Aeruginosa Infections Drugs Market Report by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
- Latin America
- Middle East & Africa
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
